Ximedica Joins Theorem Clinical Research Strategic Alliance Group
News Sep 12, 2013
Theorem Clinical Research has announced the addition of Ximedica, a medical product development firm, to its roster of strategic alliances.
With deep expertise in human factors engineering, industrial design, mechanical, electrical and software engineering, advanced manufacturing services and regulatory requirements, Ximedica brings more than 25 years of experience developing medical devices, combination products and consumer health care products to the alliance.
Ximedica’s product development experience includes programs involving complex electro-mechanical systems, fluid management systems, graphical user interfaces, portable or wearable systems and systems with cutting-edge wireless technology and miniaturization solutions.
“Theorem works with Ximedica to create design solutions that meet the safety and use requirements of a wide range of populations, thereby minimizing risk during the regulatory review process,” said D. Lee Spurgin Jr., Ph.D., Theorem senior vice president and general manager of medical device and diagnostic development.
Spurgin continued, “We feel these types of business alliances allow us to offer a better end product to clients.”
“Recognizing that a growing number of our product development programs are requiring large-scale, multi-center global clinical studies, it made sense for Ximedica to partner with a reputable, global CRO such as Theorem. Our combined expertise provides a more compelling solution for our global clients,” said Ximedica CEO Randall S. Barko.
Concept Life Sciences appoints New Group Programme Manager and US Head of SalesNews
Key leadership appointments support integration of the Group and expansion in the US market.READ MORE
Alzheimer’s Drug Discovery Foundation Announces $1.8M in New FundingNews
The Alzheimer’s Drug Discovery Foundation (ADDF) announces nearly $1.8 million in new funding, which reflects a commitment to advancing drugs in or near human clinical trials. All five funded programs are potential treatments for Alzheimer’s disease and other forms of dementia.READ MORE